Inventor · disambiguated record
Michel Sadelain
Also filed as: SADELAIN MICHEL · SADELAIN MICHEL W J
36 granted patents·44 pending applications·1,837 citations·filing 1997–2025
97Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER65SLOAN KETTERING INST CANCER6SADELAIN MICHEL3KOLESNICK RICHARD N1MEMORIAL SLOANE-KETTERING CANCER CENTER1
Top patents by PatentIndex Score
80 records- 0198US7446190B2Nucleic acids encoding chimeric T cell receptorsSLOAN KETTERING INST CANCER·Filed 2003·Granted Nov 4, 2008·904 cites·13 claims
- 0297US8389282B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesSADELAIN MICHEL·Filed 2008·Granted Mar 5, 2013·412 cites·18 claims
- 0396US9220728B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesSADELAIN MICHEL·Filed 2012·Granted Dec 29, 2015·42 cites·30 claims
- 0495US6451995B1Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methodsSLOAN KETTERING INST CANCER·Filed 1997·Granted Sep 17, 2002·335 cites·8 claims
- 0594US10654928B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted May 19, 2020·12 cites·24 claims
- 0693US10730941B2Antigen-binding proteins targeting CD56 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Aug 4, 2020·10 cites·36 claims
- 0793US10117897B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Nov 6, 2018·13 cites·26 claims
- 0892US12263220B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Granted Apr 1, 2025·1 cites·18 claims
- 0992US11242375B2Immune cell compositions and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Feb 8, 2022·5 cites·58 claims
- 1092US10370452B2Effective generation of tumor-targeted T cells derived from pluripotent stem cellsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Aug 6, 2019·21 cites·96 claims
- 1191US11702472B2Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Jul 18, 2023·2 cites·31 claims
- 1291US11267901B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Mar 8, 2022·12 cites·18 claims
- 1391US11229669B2Cells comprising non-HLA restricted T cell receptorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Jan 25, 2022·3 cites·30 claims
- 1489US11932690B2Enhanced chimeric antigen receptors and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Mar 19, 2024·4 cites·40 claims
- 1587US12275802B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Apr 15, 2025·1 cites·18 claims
- 1687US10633441B2Mesothelin-targeted chimeric antigen receptors and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 28, 2020·2 cites·41 claims
- 1786US11377637B2Transgenic T cell and chimeric antigen receptor T cell compositions and related methodsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 5, 2022·3 cites·7 claims
- 1885US8058061B2Vector encoding human globin gene and use thereof in treatment of hemoglobinopathiesSADELAIN MICHEL·Filed 2009·Granted Nov 15, 2011·4 cites·15 claims
- 1984US11717579B2Globin gene therapy for treating hemoglobinopathiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Aug 8, 2023·3 cites·61 claims
- 2084US7541179B2Vector encoding human globin gene and use thereof in treatment of hemoglobinopathiesSLOAN KETTERING INST CANCER·Filed 2002·Granted Jun 2, 2009·12 cites·24 claims
- 2183US12018077B2Methods of treatments using antigen-binding proteins targeting CD56MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Jun 25, 2024·1 cites·32 claims
- 2283US11753654B2Globin gene therapy for treating hemoglobinopathiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Sep 12, 2023·2 cites·14 claims
- 2383US10350243B2Methods for off-the-shelf-tumor immunotherapy using allogeneic T-cell precursorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Jul 16, 2019·3 cites·10 claims
- 2481US2025034228A1Immune cell compositions and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2580US2023312706A1Uses of mesothelin-targeted chimeric antigen receptorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 2678US2024294639A1Antigen-binding proteins targeting cd56 and methods of producing thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2777US12139524B2Immune cell compositions and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Nov 12, 2024·0 cites·18 claims
- 2877US10538588B2Mesothelin-targeted chimeric antigen receptors and methods of making themMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 21, 2020·1 cites·29 claims
- 2976US2024400713A1Effective generation of tumor-targeted t cells derived from pluripotent stem cellsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 3075US12345712B2Cancer antigen targets and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jul 1, 2025·0 cites·18 claims
- 3174US2022016170A1Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 3273US12404316B2Transgenic T cell and chimeric antigen receptor T cell compositions and related methodsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Sep 2, 2025·0 cites·15 claims
- 3373US11077140B2Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Aug 3, 2021·0 cites·15 claims
- 3472US2025186585A1Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 3570US12036244B2Cells comprising non-HLA restricted T cell receptorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jul 16, 2024·0 cites·21 claims
- 3670US2021069330A1Methods and compositions for tumor radiosensitizationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 3769US11712469B2Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Aug 1, 2023·0 cites·20 claims
- 3869US2025270347A1Compositions and methods for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 3969US2024166743A1Enhanced chimeric antigen receptors and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 4068US12259390B2Cancer antigen targets and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Mar 25, 2025·0 cites·13 claims
- 4167US6642043B1Double mutants of dihydrofolate reductase and methods of using sameSLOAN KETTERING INST CANCER·Filed 1997·Granted Nov 4, 2003·29 cites·12 claims
- 4267US2024123069A1Antigen recognizing receptors targeting upar and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 4367US2024398866A1Cells expressing fas ligand and cflip polypeptides and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 4466US2024066148A1Globin gene therapy for treating hemoglobinopathiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 4566US2024117066A1Anti-upar antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 4666US2024350547A1Cells Expressing FAS Ligand Polypeptides and FAS Knockout and Uses ThereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 4765US2024131070A1Antigen recognizing receptors targeting upar and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 4865US2024254253A1ANTI-uPAR ANTIBODIES AND USES THEREOFMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 4965US2018015183A1Method and composition to increase radiation-induced tumor therapeutic effectsMEMORIAL SLOANE-KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 5063US2023381315A1Cells with cd70 knockout and uses for immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michel Sadelain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →